UPDATED Apr 09, 2024
Companys with strong funding and high growth potential
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
688185 | HK$53.98 | 6.6% | -53.5% | HK$9.2b | HK$76.57 | PS11.9x | E124.2% | 0% | Pharmaceuticals & Biotech | ||
688105 | CN¥27.16 | 16.2% | -34.6% | CN¥10.9b | CN¥35.02 | PS8.6x | E94.1% | 4.5% | Pharmaceuticals & Biotech | ||
688185 | HK$51.90 | 2.4% | -55.3% | HK$9.2b | HK$71.39 | PS12.2x | E124.2% | 0% | Pharmaceuticals & Biotech | ||
688266 | CN¥52.77 | 2.7% | -6.3% | CN¥14.0b | CN¥58.54 | PS35.8x | E114.9% | n/a | Pharmaceuticals & Biotech | ||
688105 | CN¥27.70 | 18.5% | -33.3% | CN¥11.1b | CN¥35.72 | PS8.6x | E94.1% | 4.5% | Pharmaceuticals & Biotech | ||
688266 | CN¥52.28 | 1.7% | -7.1% | CN¥13.8b | CN¥58.00 | PS35.8x | E114.9% | n/a | Pharmaceuticals & Biotech | ||
688235 | US$131.16 | 4.4% | -14.8% | US$16.1b | US$228.77 | PS6.5x | E56.2% | n/a | Pharmaceuticals & Biotech | ||
688235 | US$130.48 | 3.9% | -15.2% | US$16.1b | US$227.58 | PS6.5x | E56.2% | n/a | Pharmaceuticals & Biotech |